Maite Franco Romero

Mrs. Maite Franco Romero

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MDMarije Van Doorn
Marije Van Doorn
AHAnnemien Haveman-Nies
Annemien Haveman-Nies
MBMarit M. van Bakel
Marit M. van Bakel
MFMonique Ferry
Monique Ferry
MRMaite Franco Romero
Maite Franco Romero
JVJeanne H. M. de Vries
Jeanne H. M. de Vries
This study aimed to evaluate the effects of an intervention including nutritional telemonitoring, nutrition education, and follow-up by a nurse on nutritional status, diet quality, appetite, physical functioning and quality of life of Dutch community-dwelling elderly. We used a parallel arm pre-test post-test design with 214 older adults (average age 80 years) who were allocated to the intervention group (n97) or control group (n107), based on the municipality. The intervention group received a 6-month intervention including telemonitoring measurements, nutrition education and follow-up by a nurse. Effect measurements took place at baseline, after 4·5 months, and at the end of the study. The intervention improved nutritional status of participants at risk of undernutrition (β(T1)=2·55; 95 % CI 1·41, 3·68;β(T2)=1·77; 95 % CI 0·60, 2·94) and scores for compliance with Dutch guidelines for the intake of vegetables (β=1·27; 95 % CI 0·49, 2·05), fruit (β=1·24; 95 % CI 0·60, 1·88), dietary fibre (β=1·13; 95 % CI 0·70, 1·57), protein (β=1·20; 95 % CI 0·15, 2·24) and physical activity (β=2·13; 95 % CI 0·98, 3·29). The intervention did not have an effect on body weight, appetite, physical functioning and quality of life. In conclusion, this intervention leads to improved nutritional status in older adults at risk of undernutrition, and to improved diet quality and physical activity levels of community-dwelling elderly. Future studies with a longer duration should focus on older adults at higher risk of undernutrition than this study population to investigate whether the impact of the intervention on nutritional and functional outcomes can be improved.

27 May 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
APAnna Puigdellívol-Sánchez
Anna Puigdellívol-Sánchez
MJMarta Juanes
Marta Juanes
ACAna Isabel Calderón-Valdiviezo
Ana Isabel Calderón-Valdiviezo
HLHelena Losa-Puig
Helena Losa-Puig
MSMarta González Salvador
Marta González Salvador
RVRoger VALLS-FOIX
Roger VALLS-FOIX
Background: Early pandemic reports suggested improved outcomes in hypertensive COVID-19 patients treated with angiotensin-converting enzyme inhibitors (ACEI) or amantadine. This study evaluates their impact on disease progression. Methods: We analyzed 55,936 infected patients (March 2020–January 2025) and 2024 hospital admissions within a free-access Barcelona metropolitan health consortium (n = 192,651 as of March 2025). Hospitalizations, stratified by polypharmacy level (nT), were compared via Chi-square tests. ICU admissions and length of stay in hospitalized patients were assessed during the first month of key waves: initial A2a + B3a + B9 (n = 184, March 2020), Delta (n = 158, July 2021), Omicron21K (n = 142, January 2022), and Omicron 24F (n = 8, January 2025). Results: Non-survivors were predominantly aged >60 years (96.3%) in the first wave and >70 years (100%) in Delta/Omicron waves. Post-vaccination, mortality decreased in high-comorbidity groups, though hospitalizations/ICU admissions in younger patients surpassed first-wave levels during Delta. Vaccinated ACEI/ARB-treated patients showed reduced hospitalizations across all polypharmacy groups: OR (noACEI/ACEI) = 1.21 (≥2 nT) to 4.26 (1 nT, p = 0.014); OR (noARB/ARB) = 1.24 (≥8 nT) to 1.74 (2–7 nT, p = 0.01). No hospitalizations occurred in amantadine-treated patients aged <70. Conclusions: These findings suggest a potential protective effect of ACEI, ARBs, and amantadine against severe COVID-19 and support the safety and continuity of these treatments. Multicentric studies incorporating post-COVID syndrome data are needed to validate these observations if hospitalizations persist.

JSJulia Vazquez De Sebastian
Julia Vazquez De Sebastian
Ángel Michael Ortiz ZúñigaÁngel Michael Ortiz Zúñiga
Ángel Michael Ortiz Zúñiga
Andreea Ciudin MihaiAndreea Ciudin Mihai
Andreea Ciudin Mihai
JAJoan Ars
Joan Ars
MIMarco Inzitari
Marco Inzitari
TCThe DIALCAT Consortium
The DIALCAT Consortium
The prevalence of cardiovascular risk factors (CVRFs) in the older adults population and their specific impact on their cognitive profiles still requires further research. For this purpose, a cross-sectional study was carried out to describe the presence of CVRFs and their association with cognitive performance in a sample of older adults (65–85 years old) with Mild Cognitive Impairment (MCI). Participants (n = 185) were divided into three groups concerning their cardiovascular risk level determined by the presence of different CVRFs, including Type 2 Diabetes (T2D), dyslipidemia, hypertension, and obesity. The primary outcome measures were the participant’s scores in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Sociodemographic, clinical, and psychosocial data were collected. Non-parametrical statistical analyses and effect sizes were calculated. Findings revealed that a greater presence of CVRFs was not associated with a worse overall cognitive performance. High-risk patients were more likely to have significantly worse performance in the attentional domain compared to medium-risk (p = 0.029, r = 0.42) and compared to low-risk (p = 0.041, r = 0.35), specifically in the digits repetition subtest (p = 0.042). T2D alone was the CVRF associated with cognitive differences (p = 0.037, r = 0.32), possibly mediated by the duration of the condition. Consequently, a higher presence of CVRFs did not lead to a worse overall cognitive performance. However, high-risk individuals were more likely to experience cognitive impairment, particularly in the attentional domain. T2D played a significant role in these cognitive profile differences, possibly influenced by its duration.

7 October 2026 in Journal of Nursing Scholarship
Verified
Journal Article
Closed access
PDF file
SMSusana Malgrat‐Caballero
Susana Malgrat‐Caballero
MRMaite Franco Romero
Maite Franco Romero
OPOriol Planesas‐Pérez
Oriol Planesas‐Pérez
EGEstefania Garbero Garcia
Estefania Garbero Garcia
EAEleonora Alexandrova
Eleonora Alexandrova
ARAida Ribera
Aida Ribera